Heartbeam Inc (BEAT)

개요 뉴스 가격 이력 Financials 토론 예측

Relative Volume:

Heartbeam Inc Stock (BEAT) Company Profile

Heartbeam Inc

Healthcare (1170)

408-899-4443

2118 WALSH AVE., SUITE 210, SANTA CLARA

최신 SEC 제출 서류

BEAT's Discussions on Twitter

BEAT을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
BEAT Heartbeam Inc	1.65	57.48M	0	-14.47M	-12.19M	-1.24
VEEV Veeva Systems Inc	285.36	45.71B	2.86B	780.66M	1.20B	4.72
TEM Tempus Ai Inc	62.07	9.42B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	58.85	9.78B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	111.55	8.70B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	41.16	6.92B	906.14M	-52.62M	89.62M	-0.3621

Heartbeam Inc Stock (BEAT) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2020-09-11	개시	Needham	Buy
2020-09-02	개시	Robert W. Baird	Neutral
2020-01-08	개시	SunTrust	Buy
2019-08-02	다운그레이드	Raymond James	Outperform → Mkt Perform
2019-04-26	재확인	Dougherty & Company	Buy
2018-07-26	재확인	Lake Street	Buy
2018-04-26	재확인	The Benchmark Company	Buy
2018-02-23	재확인	Dougherty & Company	Buy
2017-11-08	재확인	Dougherty & Company	Buy
2017-10-26	개시	Raymond James	Outperform
2017-10-24	개시	SunTrust	Buy
2017-08-09	재확인	Dougherty & Company	Buy
2017-07-19	재확인	The Benchmark Company	Buy
2017-04-11	재확인	Dougherty & Company	Buy
2016-12-02	개시	Dougherty & Company	Buy
2016-09-13	개시	Sidoti	Buy
2016-08-03	재확인	The Benchmark Company	Buy
2015-07-28	재확인	Dougherty & Company	Buy
2013-10-24	개시	The Benchmark Company	Buy
2013-08-21	개시	Dougherty & Company	Buy

Heartbeam Inc 주식(BEAT)의 최신 뉴스

Heartbeam Inc (BEAT) 재무 분석

Heartbeam Inc (BEAT)

Heartbeam Inc Stock (BEAT) Company Profile

BEAT을(를) 다른 주식과 비교

Heartbeam Inc Stock (BEAT) Upgrades & Downgrades

Heartbeam Inc 주식(BEAT)의 최신 뉴스

HeartBeam CEO Named to Company’s Board of Directors - Medical Product Outsourcing

Benchmark maintains $8 target on Heartbeam stock post-1Q report - Investing.com Australia

Benchmark maintains $8 target on Heartbeam stock post-1Q report By Investing.com - Investing.com India

HeartBeam’s Positive Earnings Call Reflects Growth Potential - TipRanks

HeartBeam, Inc. (NASDAQ:BEAT) Q1 2025 Earnings Call Transcript - Insider Monkey

HeartBeam (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update - Barchart.com

HeartBeam (BEAT) Reports Advancements in Q1 2025 | BEAT Stock Ne - GuruFocus

HeartBeam reports net loss of USD 5.5M in Q1 2025 - Medical Buyer

HeartBeam, Inc. Reports Q1 2025 Financial Results - TipRanks

Earnings call transcript: HeartBeam Q1 2025 miss doesn’t deter investors By Investing.com - Investing.com South Africa

Heartbeam Inc reports results for the quarter ended March 31Earnings Summary - TradingView

HeartBeam Q1 2025 slides: FDA progress and commercial readiness amid continued losses - Investing.com Nigeria

HeartBeam, Inc. SEC 10-Q Report - TradingView

HeartBeam Reports First Quarter 2025 Results - Business Wire

The Week in Canadian Press Releases: 10 Stories You Need to See - The Globe and Mail

HeartBeam strengthens IP with US patents for cardiac monitoring - Yahoo Finance

Two New U.S. Patents Bring Total to 20 Issued Worldwide, - openPR.com

Two New U.S. Patents Bring Total to 20 Issued Worldwide, Cementing Company Leadership in Cardiac Monitoring Innovation for 12-Lead ECG Synthesis Technology: HeartBeam, Inc. (Nasdaq: BEAT) - Barchart.com

HeartBeam Secures 2 New U.S. Patents - Medical Product Outsourcing

HeartBeam (NASDAQ: BEAT) Adds Two U.S. Patents to Bolster Cardiac Monitoring IP Portfolio - Barchart.com

HeartBeam (BEAT) Expands IP Portfolio with New U.S. Patents | BEAT Stock News - GuruFocus

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio - Business Wire

HeartBeam Expands Board with CEO Robert Eno’s Appointment - citybuzz -

HeartBeam (NASDAQ: BEAT) Appoints CEO Robert Eno To Board Of Directors - Barchart.com

HeartBeam (BEAT) Welcomes CEO Robert Eno to Its Board of Directo - GuruFocus

HeartBeam Appoints CEO Robert Eno to Board - TipRanks

HeartBeam expands board, appoints CEO to director role By Investing.com - Investing.com India

HeartBeam expands board, appoints CEO to director role - Investing.com Australia

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth - Bluefield Daily Telegraph

HeartBeam, Inc. Appoints Robert Eno to Board of Directors - marketscreener.com

HeartBeam (NASDAQ: BEAT) Prices $10 Million Public Offering At $1.70 Per Share - Barchart.com

HeartBeam (NASDAQ: BEAT) to Report Q1 2025 Results and Provide Business Update on May 13 - Barchart.com

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time - Bluefield Daily Telegraph

HeartBeam’s ECG technology shows promise in study for arrhythmia diagnosis - Yahoo Finance

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology - BioSpace

Strategic Collaboration with AccurKardia for Ambulatory ECG - openPR.com

Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care: HeartBeam, Inc. (Nasdaq: BEAT) - The Globe and Mail

Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care: HeartBeam, Inc. (Nasdaq: BEAT) | FinancialContent - FinancialContent

HeartBeam (NASDAQ: BEAT) Reports Positive VALID-ECG Study Results Supporting 12-Lead ECG Tech - Barchart.com

HeartBeam’s VALID-ECG Study of 12-Lead ECG Synthesis Tech Meets Endpoints - Medical Product Outsourcing

HeartBeam (BEAT) Achieves Key Milestones with Synthesized 12-Lea - GuruFocus

HeartBeam’s ECG software shows promise in clinical study - Investing.com

HeartBeam’s ECG software shows promise in clinical study By Investing.com - Investing.com India

HeartBeam announces VALID-ECG pivotal study met primary endpoint - TipRanks

Heartbeam Inc (BEAT) 재무 분석

매출

순이익

현금흐름

주당 순 이익

BEAT과 유사한 종목